Simple method to evaluate specificity of osteocalcin immunoassays

Clinical Chemistry

Volumn 43, Issue 9, 1997, Pages 1663-1664

  Souberbielle, Jean Claude ^a   Marque, Delphine ^a   Bonnet, Philippe ^a   Herviaux, Patricia ^a   Sachs, Charles ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN;

ARTICLE; BONE MATRIX; BONE TURNOVER; DIAGNOSTIC ACCURACY; HEMODIALYSIS; HUMAN; IMMUNOASSAY; OSTEOBLAST; OSTEOPOROSIS;

EID: 0030853778     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.9.1663     Document Type: Article

References (11)

1. Price PA, Parthemore JG, Deftos LJ. New biochemical marker for bone metabolism. J Clin Invest 1980;66:878-83.
2. Delmas PD, Malaval L, Arlot ME, Meunier PJ. Serum bone GLA protein compared to bone histomorphometry in endocrine diseases. Bone 1985;6: 329-41.
3. Prummel MF, Wiersing WM, Lips P, Sanders GT, Sauerhein HP. The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 1991;72:383-6.
4. Delmas PD, Christiansen C, Mann KG, Price PA. Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 1990;5:5-11.
5. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM. Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 1994;40:358-63.
6. Garnero P, Grimaux M, Seguin P, Delmas PD. Characterization of immunoreactive forms of human osteocalcin generated in vivo and in vitro. J Bone Miner Res 1994;9:255-64.
7. Gundberg C, Weinstein R. Multiple immunoreactive forms of osteocalcin in uremic serum. J Clin Invest 1986;77:1762-7.
8. Rosenqvist C, Qvist P, Bjarnason N, Christiansen C. Measurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies. Clin Chem 1995;41:1439-45.
9. Urena P, Ferreira A, Kung V. Morieux C. Simon P, Ang K, et al. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J Bone Miner Res 1995;10:932-9.
10. Gamero P, Grimaux M, Demiaux B, Preaudat C, Seguin P, Delmas PD. Measurement of serum osteocalcin with a human-specific two-site immunoradiometric assay. J Bone Miner Res 1992;7:1389-98.
11. Chen JT, Hosoda K, Hasumi K, Ogata E, Shiraki M. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. J Bone Miner Res 1996;11:1784-92.